Public Companies
Reunion Neuroscience Exec Steps Down as Director
Psychedelic drug maker Reunion Neuroscience (Nasdaq: REUN), formerly known as Field Trip Health, announced that Ronan Levy has stepped down from the board…
Psychedelic drug maker Reunion Neuroscience (Nasdaq: REUN), formerly known as Field Trip Health, announced that Ronan Levy has stepped down from the board and resigned his post as director.
Levy co-founded Field Trip Health.
The company’s corporate secretary and general counsel, Paula Amy Hewitt, also resigned.
“The company wishes both Ronan and Paula much success in their future endeavors and greatly appreciates the contributions that they made to support Reunion as it transitioned to a stand-alone entity,” a spokesperson told Green Market Report.
The news follows Reunion’s recent tapping of Greg Mayes as president and CEO. Mayes has been poised to replace Levy since the Sept. 28 announcement.
A company spokesperson said that Hewitt served Reunion as corporate secretary, but “was not employed by the company.”
“As such, Reunion needed to align its board support with an existing employee,” the spokesperson added.
CFO Donna Wong will fill Hewitt’s post as legal advisor.
The post Reunion Neuroscience Exec Steps Down as Director appeared first on Green Market Report.
psychedelic nasdaq field trip health field trip-
Psilocybin1 week ago
Psychedelic Underground Celebrated in San Francisco on Bicycle Day Weekend
-
Psychedelics7 days ago
Compass Pathways and Journey Clinical Establish Research Collaboration Agreement To Inform the Training of Healthcare Providers and Delivery Model for COMP360 Psilocybin Treatment, If Approved for Treatment-Resistant Depression
-
Psychedelics7 days ago
Cybin to Participate at the 27th Annual Milken Institute Global Conference
-
Psychedelics6 days ago
Freedom Biosciences Announces FDA Approval of IND Application for FREE001 in Patients with Treatment-Resistant Depression
-
Law & Regulation5 days ago
Compass Pathways, Journey Clinical to develop psilocybin treatment delivery model
-
Psychedelics6 days ago
Behold! A New Mushroom Emoji Has Arrived!
-
Ketamine5 days ago
DEA poised to move cannabis to Schedule III
-
Psychedelics6 days ago
Behold! A New Mushroom Emoji Has Arrived!